Moneycontrol PRO
UPCOMING EVENT:Watch leaders discuss the biggest issue of our times at the Sustainability 100+ Summit. Register now!
you are here: HomeNewsIndia

Over 57.16 crore Covid vaccine doses administered in India: Health Ministry

The cumulative vaccination coverage of 57,16,71,264 doses is segregated on the basis of population priority groups, the ministry said.

August 19, 2021 / 10:55 PM IST
(Representative image: Reuters)

(Representative image: Reuters)

The total number of COVID-19 vaccine doses administered in the country has crossed 57.16 crore, including over 48 lakh doses given on Thursday, according to the Union health ministry.

While 26,66,831 beneficiaries in the age group of 18-44 years received the first dose, 6,01,437 were administered the second dose of the vaccine on Thursday, the ministry said in a statement.

"Cumulatively, 21,13,11,218 persons in the age group of 18-44 years across 37 states and Union territories have received their first dose and a total of 1,79,43,325 have received their second dose since the start of Phase-3 of the vaccination drive," it said.

The cumulative vaccination coverage of 57,16,71,264 doses is segregated on the basis of population priority groups, the ministry said.

On the 216th day (August 19) of the vaccination drive, a total of 48,84,440 vaccine doses were given -- 36,35,752 beneficiaries received the first dose and 12,48,688 were administered the second dose -- according to a provisional report compiled at 7 pm. The final report for the day would be compiled by late night.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Follow our full coverage of the coronavirus pandemic here.
first published: Aug 19, 2021 10:54 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark